Spectral Medical Inc.
EDT.TO
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 147.32% | -158.16% | -1.95% | -266.72% | -158.22% |
| Total Depreciation and Amortization | 51.92% | -3.14% | 13.91% | 5.50% | -40.08% |
| Total Amortization of Deferred Charges | -105.29% | -28.97% | 1,805.38% | 189.27% | -- |
| Total Other Non-Cash Items | -229.86% | 705.74% | -34.94% | 539.23% | 711.24% |
| Change in Net Operating Assets | -115.35% | 73.01% | -22.65% | 139.48% | 75.13% |
| Cash from Operations | -3.99% | 4.46% | -12.39% | 64.86% | 5.22% |
| Capital Expenditure | 100.56% | 51.67% | -11.54% | -- | -397.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.56% | 51.67% | -11.54% | -- | -397.62% |
| Total Debt Issued | 100.00% | -78.41% | -- | -- | -159.55% |
| Total Debt Repaid | 70.08% | -161.90% | -43.33% | 0.00% | -4,133.33% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -117.33% | 63.55% | -427.66% | -- | 60.81% |
| Cash from Financing | -297.34% | -79.82% | 3,013.58% | 1,200.41% | -97.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.54% | -169.63% | 326.73% | 75.03% | -128.72% |